Extremely High Rate Of Complete Hematological Response Of Elderly Ph Plus Acute Lymphoblastic Leukemia (All) Patients By Innovative Sequential Use Of Nilotinib And Imatinib. A Gimema Protocol Lal 1408

CANCER RESEARCH(2014)

引用 3|浏览23
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要